Abstract
Stearoyl-CoA desaturase 1 (SCD1) plays a role in the development of obesity and related conditions, such as insulin resistance, and potentially also in neurological and heart diseases. The activity of SCD1 can be monitored using the desaturation index (DI), the ratio of product (16:1n-7 and 18:1n-9) to precursor (16:0 and 18:0) fatty acids. Here, different analytical strategies were applied to identify the method which best supports SCD1 biology. A novel effective approach was the use of the SCD1-independent fatty acid (16:1n-10) as a negative control. The first approach was based on a simple extraction followed by neutral loss triglyceride fatty acid analysis. The second approach was based on the saponification of triglycerides followed by fatty acid analysis (specific for the position of the double bond within monounsaturated fatty acids (MUFAs)). In addition to the analytical LC-MS assays, different matrices (plasma total triglyceride fraction and the very low-density lipoprotein (VLDL) fraction) were investigated to identify the best for studying changes in SCD1 activity. Samples from volunteers on a high-carbohydrate diet were analyzed. Both ultra HPLC (UHPLC)-MS-based assays showed acceptable accuracies (75–125 % of nominal) and precisions (<20 %) for the analysis of DI-specific fatty acids in VLDL and plasma. The most specific assay for the analysis of the liver SCD activity was then validated for specificity and selectivity, intra- and interday accuracy and precision, matrix effects, dilution effects, and analyte stability. After 3 days of high-carbohydrate diet, only the specific fatty acids in human plasma VLDL showed a significant increase in DI and associated SCD1 activity.
Similar content being viewed by others
References
Weiss K, Mihaly J, Liebisch G, Marosvolgyi T, Schmitz G, Decsi T, Ruhl R (2011) Lipids 46:1013–1020
Sampath H, Ntambi JM (2011) Ann N Y Acad Sci 1243:47–53
Chajes V, Joulin V, Clavel-Chapelon F (2011) Curr Opin Lipidol 22:6–10
Chajes V, Hulten K, Van Kappel AL, Winkvist A, Kaaks R, Hallmans G, Lenner P, Riboli E (1999) Int J Cancer 83:585–590
Chajes V, Hulten K, Van Kappel AL, Winkvist A, Kaaks R, Hallmans G, Lenner PG, Riboli E (1999) Lipids 34:S113
Liu X, Strable MS, Ntambi JM (2011) Adv Nutr 2:15–22
Kim YC, Ntambi JM (1999) Biochem Biophys Res Commun 266:1–4
Flowers MT, Ntambi JM (2008) Curr Opin Lipidol 19:248–256
Collins JM, Neville MJ, Hoppa MB, Frayn KN (2010) J Biol Chem 285:6044–6052
Postic C, Girard J (2008) J Clin Invest 118:829–838
Miyazaki M, Kim YC, Gray-Keller MP, Attie AD, Ntambi JM (2000) J Biol Chem 275:30132–30138
Flowers MT, Ntambi JM (2009) Biochim Biophys Acta 1791:85–91
Paton CM, Ntambi JM (2009) Am J Physiol Endocrinol Metab 297:E28–E37
Barrows BR, Parks EJ (2006) J Clin Endocrinol Metab 91:1446–1452
Magkos F, Patterson BW, Mittendorfer B (2006) Am J Physiol Endocrinol Metab 291:E1243–E1249
Vedala A, Wang W, Neese RA, Christiansen MP, Hellerstein MK (2006) J Lipid Res 47:2562–2574
Diraison F, Moulin P, Beylot M (2003) Diabetes Metab 29:478–485
Magkos F (2009) Prog Lipid Res 48:171–190
Mittendorfer B, Patterson BW, Klein S, Sidossis LS (2003) Am J Physiol Endocrinol Metab 284:E708–E715
Mittendorfer B, Patterson BW, Klein S (2003) Am J Physiol Endocrinol Metab 284:E549–E556
Barter PJ, Nestel PJ (1973) Metabolism 22:779–783
Roongta UV, Pabalan JG, Wang X, Ryseck RP, Fargnoli J, Henley BJ, Yang WP, Zhu J, Madireddi MT, Lawrence RM, Wong TW, Rupnow BA (2011) Mol Cancer Res 9:1551–1561
Chajes V, Jenab M, Romieu I, Ferrari P, Dahm CC, Overvad K, Egeberg R, Tjonneland A, Clavel-Chapelon F, Boutron-Ruault MC, Engel P, Teucher B, Kaaks R, Floegel A, Boeing H, Trichopoulou A, Dilis V, Karapetyan T, Mattiello A, Tumino R, Grioni S, Palli D, Vineis P, Bueno-de-Mesquita HB, Numans ME, Peeters PH, Lund E, Navarro C, Quiros JR, Sanchez-Cantalejo E, Gurrea AB, Dorronsoro M, Regner S, Sonestedt E, Wirfalt E, Khaw KT, Wareham N, Allen NE, Crowe FL, Rinaldi S, Slimani N, Carneiro F, Riboli E, Gonzalez CA (2011) Am J Clin Nutr 94:1304–1313
Peter A, Cegan A, Wagner S, Lehmann R, Stefan N, Konigsrainer A, Konigsrainer I, Haring HU, Schleicher E (2009) Clin Chem 55:2113–2120
Brousseau T, Clavey V, Bard JM, Fruchart JC (1993) Clin Chem 39:960–964
McEneny J, McMaster C, Trimble ER, Young IS (2002) J Lipid Res 43:824–831
Burdge GC, Wright P, Jones AE, Wootton SA (2000) Br J Nutr 84:781–787
Kaluzny MA, Duncan LA, Merritt MV, Epps DE (1985) J Lipid Res 26:135–140
Folch J, Lees M, Sloane Stanley GH (1957) J Biol Chem 226:497–509
Fisher EA (2012) Biochim Biophys Acta 1821:778–781
Dunphy PJ, Whittle KJ, Pennock JF (1965) Chem Ind 27:1217–1218
Zivkovic AM, Wiest MM, Nguyen UT, Davis R, Watkins SM, German JB (2009) Metabolomics 5:507–516
Petersson H, Basu S, Cederholm T, Riserus U (2008) Br J Nutr 99:1186–1189
Sjogren P, Sierra-Johnson J, Gertow K, Rosell M, Vessby B, de Faire U, Hamsten A, Hellenius ML, Fisher RM (2008) Diabetologia 51:328–335
Attie AD, Krauss RM, Gray-Keller MP, Brownlie A, Miyazaki M, Kastelein JJ, Lusis AJ, Stalenhoef AF, Stoehr JP, Hayden MR, Ntambi JM (2002) J Lipid Res 43:1899–1907
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 2.86 mb)
Rights and permissions
About this article
Cite this article
Klawitter, J., Bek, S., Zakaria, M. et al. Fatty acid desaturation index in human plasma: comparison of different analytical methodologies for the evaluation of diet effects. Anal Bioanal Chem 406, 6399–6408 (2014). https://doi.org/10.1007/s00216-014-8020-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-014-8020-4